FI935617A - 3,5-substituoituja aminobentsoyyliguanidiineja, menetelmä niiden valmistamiseksi, niiden käyttö lääkkeinä tai diagnostisina aineina sekä niitä sisältävä lääke - Google Patents

3,5-substituoituja aminobentsoyyliguanidiineja, menetelmä niiden valmistamiseksi, niiden käyttö lääkkeinä tai diagnostisina aineina sekä niitä sisältävä lääke Download PDF

Info

Publication number
FI935617A
FI935617A FI935617A FI935617A FI935617A FI 935617 A FI935617 A FI 935617A FI 935617 A FI935617 A FI 935617A FI 935617 A FI935617 A FI 935617A FI 935617 A FI935617 A FI 935617A
Authority
FI
Finland
Prior art keywords
medicinal
properties
aminobenzoylguanidines
substituted
preparation
Prior art date
Application number
FI935617A
Other languages
English (en)
Swedish (sv)
Other versions
FI113860B (fi
FI935617A0 (fi
Inventor
Hans-Jochen Lang
Heinrich Englert
Andreas Weichert
Heinz-Werner Kleeman
Wolfgang Scholz
Udo Albus
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI935617A0 publication Critical patent/FI935617A0/fi
Publication of FI935617A publication Critical patent/FI935617A/fi
Application granted granted Critical
Publication of FI113860B publication Critical patent/FI113860B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI935617A 1992-12-16 1993-12-14 Menetelmä terapeuttisesti käyttökelpoisten 3,5-substituoitujen aminobentsoyyliguanidiinien valmistamiseksi FI113860B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4242554 1992-12-16
DE4242554 1992-12-16

Publications (3)

Publication Number Publication Date
FI935617A0 FI935617A0 (fi) 1993-12-14
FI935617A true FI935617A (fi) 1994-06-17
FI113860B FI113860B (fi) 2004-06-30

Family

ID=6475499

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935617A FI113860B (fi) 1992-12-16 1993-12-14 Menetelmä terapeuttisesti käyttökelpoisten 3,5-substituoitujen aminobentsoyyliguanidiinien valmistamiseksi

Country Status (17)

Country Link
US (1) US5516805A (fi)
EP (1) EP0603650B1 (fi)
JP (1) JP3875731B2 (fi)
AT (1) ATE151071T1 (fi)
AU (1) AU664930B2 (fi)
CA (1) CA2111512C (fi)
DE (1) DE59306029D1 (fi)
DK (1) DK0603650T3 (fi)
ES (1) ES2100435T3 (fi)
FI (1) FI113860B (fi)
GR (1) GR3023634T3 (fi)
HU (1) HU215438B (fi)
IL (1) IL108027A (fi)
NO (1) NO300416B1 (fi)
NZ (1) NZ250450A (fi)
TW (1) TW384281B (fi)
ZA (1) ZA939360B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
EP0612723B1 (de) * 1993-02-20 1997-08-27 Hoechst Aktiengesellschaft Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, als Inhibitoren des zellulären Na+/H+-Austauschs oder als Diagnostikum sowie sie enthaltendes Medikament
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4325822A1 (de) * 1993-07-31 1995-02-02 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4337611A1 (de) * 1993-11-04 1995-05-11 Boehringer Ingelheim Kg Neue Benzoylguanidine, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4422685A1 (de) * 1994-06-29 1996-01-04 Hoechst Ag Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
IL114670A0 (en) * 1994-08-05 1995-11-27 Fujisawa Pharmaceutical Co Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
DE4430213A1 (de) * 1994-08-28 1996-02-29 Merck Patent Gmbh Arylbenzoylguanidine
DE4430916A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl-benzoylguanidin-Derivate
EP0765867A1 (de) * 1995-09-27 1997-04-02 Hoechst Aktiengesellschaft Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament
DE19540995A1 (de) * 1995-11-03 1997-05-07 Hoechst Ag Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PL316439A1 (en) * 1995-11-20 1997-05-26 Hoechst Ag Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
ATE440827T1 (de) * 2002-12-04 2009-09-15 Ore Pharmaceuticals Inc Melanocortin-rezeptormodulatoren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
GB9016579D0 (en) * 1990-07-27 1990-09-12 Ici Plc Fungicides

Also Published As

Publication number Publication date
FI113860B (fi) 2004-06-30
IL108027A (en) 1998-12-06
NO934634D0 (no) 1993-12-15
US5516805A (en) 1996-05-14
NZ250450A (en) 1995-08-28
HUT65747A (en) 1994-07-28
DE59306029D1 (de) 1997-05-07
ATE151071T1 (de) 1997-04-15
AU664930B2 (en) 1995-12-07
HU9303596D0 (en) 1994-04-28
ZA939360B (en) 1994-08-08
JPH06256290A (ja) 1994-09-13
CA2111512A1 (en) 1994-06-17
TW384281B (en) 2000-03-11
AU5240593A (en) 1994-06-30
EP0603650A1 (de) 1994-06-29
IL108027A0 (en) 1994-04-12
NO934634L (no) 1994-06-17
HU215438B (hu) 2000-12-28
JP3875731B2 (ja) 2007-01-31
ES2100435T3 (es) 1997-06-16
DK0603650T3 (da) 1997-10-20
FI935617A0 (fi) 1993-12-14
EP0603650B1 (de) 1997-04-02
CA2111512C (en) 2005-11-15
NO300416B1 (no) 1997-05-26
GR3023634T3 (en) 1997-08-29

Similar Documents

Publication Publication Date Title
FI935617A (fi) 3,5-substituoituja aminobentsoyyliguanidiineja, menetelmä niiden valmistamiseksi, niiden käyttö lääkkeinä tai diagnostisina aineina sekä niitä sisältävä lääke
DE69219221T2 (de) Vanadium Komplexe, ihre Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
DE69112989T2 (de) Aminocoumaranderivate, ihre Herstellung und Verwendung.
ES8605511A1 (es) Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos.
AU643282B2 (en) Liposomes with positive excess charge
FI946039A (fi) Substituoidut 1-okso-1,2-dihydro-isokinolinoyyli- ja 1,1-diokso-2H-1,2-bentsotiatsinoyyliguanidiinit, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine
ES2091359T3 (es) Nuevo compuesto peptidico y un procedimiento para su preparacion.
AU624951B2 (en) New sulfonamides derived from benzocyclic or benzoheterocyclic acids, their preparation and application in thereapeutics
DE69311118T2 (de) Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung
DE3575554D1 (de) Aminosaeurederivate mit antitumoraktivitaet sowie diese derivate enthaltende zusammensetzungen.
ES2111019T3 (es) Derivados de espicamicina y utilizacion de los mismos.
NZ332575A (en) Sulfonamide-substituted benzopyran derivatives, processes for preparation, medicament use and compositions comprising them
ES8104210A1 (es) Un procedimiento para la preparacion de un compuesto de biu-ret 1,1,3,5-sustituido.
ATE772T1 (de) Thiazolderivate, ihre herstellung und sie enthaltende arzneimittel.
MY101827A (en) 2-[n-substitutedguanidino]-4-heteroarylthiazole antiulcer agents
TH18165A (th) สารยับยั้งการเกิดคีโมแทกซิของอีโอซีโนฟีล
GB1348558A (en) Meta-bis-anilide derivatives and their use as herbicides

Legal Events

Date Code Title Description
MM Patent lapsed